Interpharm Holdings Stock Buy Hold or Sell Recommendation
| IPAH Stock | USD 0 0.00 0.00% |
Given the investment horizon of 90 days and your slightly conservative level of risk, our recommendation regarding Interpharm Holdings is 'Strong Sell'. The recommendation algorithm takes into account all of Interpharm Holdings' available fundamental, technical, and predictive indicators you will find on this site.
Check out Interpharm Holdings Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in Interpharm Stock please use our How to Invest in Interpharm Holdings guide. In addition, we conduct extensive research on individual companies such as Interpharm and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Interpharm Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Interpharm | Build AI portfolio with Interpharm Stock |
Execute Interpharm Holdings Buy or Sell Advice
The Interpharm recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Interpharm Holdings. Macroaxis does not own or have any residual interests in Interpharm Holdings or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Interpharm Holdings' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Interpharm Holdings Trading Alerts and Improvement Suggestions
| Interpharm Holdings generated a negative expected return over the last 90 days | |
| Interpharm Holdings has some characteristics of a very speculative penny stock | |
| Interpharm Holdings currently holds 12.06 M in liabilities with Debt to Equity (D/E) ratio of 3.43, implying the company greatly relies on financing operations through barrowing. Interpharm Holdings has a current ratio of 0.61, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Interpharm Holdings' use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 75.59 M. Net Loss for the year was (14.06 M) with profit before overhead, payroll, taxes, and interest of 12 M. | |
| Interpharm Holdings currently holds about 41 K in cash with (14.11 M) of positive cash flow from operations. | |
| Interpharm Holdings has a poor financial position based on the latest SEC disclosures |
Interpharm Holdings Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Interpharm Holdings or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Interpharm Holdings' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Interpharm stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 0.00 | |
Ir | Information ratio | 0.00 |
Interpharm Holdings Volatility Alert
At this time Interpharm Holdings exhibits very low volatility. Interpharm Holdings is a penny stock. Even though Interpharm Holdings may be a good instrument to invest, many penny stocks are speculative instruments that are subject to artificial stock promotions. Please make sure you fully understand upside and downside scenarios of investing in Interpharm Holdings or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings,sudden promotions and many other similar artificial hype indicators. We also encourage traders to check work history of company executives before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Interpharm instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Interpharm Holdings Fundamentals Vs Peers
Comparing Interpharm Holdings' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Interpharm Holdings' direct or indirect competition across all of the common fundamentals between Interpharm Holdings and the related equities. This way, we can detect undervalued stocks with similar characteristics as Interpharm Holdings or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Interpharm Holdings' fundamental indicators could also be used in its relative valuation, which is a method of valuing Interpharm Holdings by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Interpharm Holdings to competition |
| Fundamentals | Interpharm Holdings | Peer Average |
| Return On Equity | -1.17 | -0.31 |
| Return On Asset | -0.19 | -0.14 |
| Profit Margin | (0.42) % | (1.27) % |
| Operating Margin | (0.24) % | (5.51) % |
| Current Valuation | 2.07 M | 16.62 B |
| Number Of Shares Shorted | 1.13 M | 4.71 M |
| Price To Sales | 0.03 X | 11.42 X |
| Revenue | 75.59 M | 9.43 B |
| Gross Profit | 12 M | 27.38 B |
| EBITDA | (16.57 M) | 3.9 B |
| Net Income | (14.06 M) | 570.98 M |
| Cash And Equivalents | 41 K | 2.7 B |
| Total Debt | 12.06 M | 5.32 B |
| Debt To Equity | 3.43 % | 48.70 % |
| Current Ratio | 0.62 X | 2.16 X |
| Book Value Per Share | (0.08) X | 1.93 K |
| Cash Flow From Operations | (14.11 M) | 971.22 M |
| Short Ratio | 289.66 X | 4.00 X |
| Earnings Per Share | (0.09) X | 3.12 X |
| Number Of Employees | 670 | 18.84 K |
| Beta | -59.92 | -0.15 |
| Market Capitalization | 2.07 M | 19.03 B |
| Total Asset | 74.37 M | 29.47 B |
| Working Capital | (16.64 M) | 1.48 B |
| Current Asset | 27.38 M | 9.34 B |
| Current Liabilities | 44.01 M | 7.9 B |
| Net Asset | 74.37 M |
Interpharm Holdings Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Interpharm . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 0.0041 | |||
| Day Typical Price | 0.0041 |
About Interpharm Holdings Buy or Sell Advice
When is the right time to buy or sell Interpharm Holdings? Buying financial instruments such as Interpharm Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Interpharm Holdings in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Utilities ETFs Thematic Idea Now
Utilities ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Utilities ETFs theme has 15 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Utilities ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Interpharm Holdings Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in Interpharm Stock please use our How to Invest in Interpharm Holdings guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Interpharm Holdings. If investors know Interpharm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Interpharm Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.09) | Revenue Per Share | Quarterly Revenue Growth (0.07) | Return On Assets | Return On Equity |
The market value of Interpharm Holdings is measured differently than its book value, which is the value of Interpharm that is recorded on the company's balance sheet. Investors also form their own opinion of Interpharm Holdings' value that differs from its market value or its book value, called intrinsic value, which is Interpharm Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Interpharm Holdings' market value can be influenced by many factors that don't directly affect Interpharm Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Interpharm Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Interpharm Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Interpharm Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.